{"publish_date":{"18716597":20151008,"18692200":20151008},"url":{"18716597":"http:\/\/www.sci-tech-today.com\/news\/Health-Fears-in-Flooding-s-Aftermath\/story.xhtml?story_id=020000F8XBF8","18692200":"http:\/\/www.4-traders.com\/news\/Treatment-Effects-Maintained-Over-Five-Years-in-Majority-of-Patients-with-Relapsing-Remitting-Multip--21163611\/"},"topic":{"18716597":"moldf","18692200":"moldf"},"model1_prediction":{"18716597":1,"18692200":1},"model1_prediction_prob":{"18716597":0.8664564821,"18692200":0.5085618631},"title":{"18716597":"Health Concerns Abound in Aftermath of Flooding","18692200":"Treatment Effects Maintained Over Five Years in Majority of Patients with Relapsing Remitting Multiple Sclerosis who Received Genzyme\u2019s Lemtrada\u00ae (alemtuzumab) in Clinical Trials"}}